• Disrupting the c-MYC–G9a–FTH1 Axis in Breast Cancer by Dual

  2026-04-14

  This study demonstrates that combined inhibition of BRD4 and RAC1 in breast cancer cells disrupts the oncogenic c-MYC–G9a–FTH1 pathway and downregulates HDAC1, leading to reduced tumor growth, stemness, and tumorigenic potential. The mechanistic insights highlight new epigenetic vulnerabilities for targeting diverse molecular subtypes of breast cancer.

• Bay 11-7821: Bridging Inflammatory Pathways to Translational

  2026-04-13

  This thought-leadership article dissects Bay 11-7821’s mechanistic role as a selective IKK inhibitor, contextualizing its utility for translational researchers investigating inflammatory signaling and apoptosis regulation. Integrating fresh mechanistic insights from recent sepsis research, the article situates Bay 11-7821 within the evolving landscape of inflammation and cancer biology, and provides actionable protocol guidance and a critical competitive assessment. The discussion moves beyond typical product summaries, connecting bench findings to clinical horizons and highlighting the compound’s translational promise.

• CX-5461: Redefining RNA Polymerase I Inhibition in Cancer Re

  2026-04-12

  CX-5461, a potent RNA polymerase I inhibitor, is transforming translational cancer research by targeting ribosomal RNA synthesis and exploiting vulnerabilities in tumor cell proliferation and survival. This thought-leadership article explores mechanistic insights, recent experimental evidence, and strategic guidance for leveraging CX-5461 in advanced cancer models. By connecting recent breakthroughs—including synergy with cisplatin and induction of mitotic catastrophe—to actionable protocols and competitive positioning, we outline a roadmap for researchers to drive impactful translational outcomes.

• GSK J4 HCl: Pioneering JMJD3 Inhibition in Immune Regulation

  2026-04-12

  Explore how GSK J4 HCl, a potent JMJD3 inhibitor, uniquely illuminates the links between histone demethylation, immune modulation, and inflammation. This article delivers advanced scientific insight and practical assay considerations for epigenetic regulation research.

• DMH1: A Selective ALK2 Inhibitor Empowering Organoid & NSCLC

  2026-04-11

  DMH1’s precision as a selective ALK2 inhibitor unlocks unprecedented control over the BMP pathway, enabling researchers to fine-tune self-renewal and differentiation in organoids and to inhibit tumorigenic signaling in non-small cell lung cancer models. This guide delivers actionable protocols, troubleshooting strategies, and evidence-based insights for maximizing DMH-1’s impact in both advanced tissue engineering and translational oncology.

• KU-55933: Precision ATM Kinase Inhibitor for DNA Damage Rese

  2026-04-11

  KU-55933 stands out as a potent and highly selective ATM kinase inhibitor, enabling researchers to dissect DNA damage response and cell cycle arrest mechanisms with exceptional clarity. Its robust solubility profile and proven efficacy in cancer cell viability studies empower advanced workflows from iPSC-based disease modeling to metabolic assays.

• Oligo (dT) 25 Beads: Magnetic Bead-Based mRNA Purificatio...

  2026-04-10

  Oligo (dT) 25 Beads empower researchers with rapid, high-yield eukaryotic mRNA isolation, directly streamlining workflows from total RNA to next-generation sequencing. Discover how these superparamagnetic beads outperform traditional methods in sensitivity, specificity, and workflow integration—enabling robust transcriptomics and functional genomics in animal and plant research.

• D-Luciferin Potassium Salt: High-Performance Bioluminesce...

  2026-04-09

  D-Luciferin (potassium salt) elevates bioluminescence imaging by combining enhanced water solubility with exceptional purity—enabling sensitive, real-time tracking of tumor, stem, and pathogen cells in live animal models. Backed by peer-reviewed research and translational breakthroughs, this firefly luciferase substrate empowers reproducible, high-throughput applications from cancer immunotherapy to advanced drug discovery.

• Adefovir: HBV DNA Polymerase Inhibition and Research Utility

  2026-04-08

  Adefovir is a nucleotide analog antiviral agent that inhibits hepatitis B virus (HBV) DNA polymerase with high selectivity. It acts as a benchmark inhibitor and renal OAT1 probe in antiviral and transporter research. This article provides atomic, verifiable details on Adefovir’s mechanism, evidence, and optimal use, supporting advanced HBV research workflows.

• Rotigotine hydrochloride: Dopamine D2/D3 Receptor Agonist...

  2026-04-08

  Rotigotine hydrochloride is a full dopamine D2/D3 receptor agonist widely used in Parkinson’s disease and neurodegeneration research. It demonstrates neuroprotective and antioxidant effects, and is validated in both in vitro and in vivo models. This article aggregates mechanistic, benchmarking, and workflow data for reproducible dopaminergic signaling studies.

• Adefovir: HBV DNA Polymerase Inhibition and OAT1 Probe Be...

  2026-04-07

  Adefovir is a nucleotide analog antiviral agent with proven specificity for hepatitis B virus (HBV) DNA polymerase inhibition and serves as a validated substrate for renal organic anion transporter 1 (OAT1). Its robust antiviral mechanism, defined pharmacokinetics, and precise application parameters make it a reference standard in HBV research and renal transporter assays.

• D-Luciferin (Potassium Salt): Gold-Standard Substrate for...

  2026-04-07

  D-Luciferin (potassium salt) is a highly water-soluble, high-purity substrate for firefly luciferase, widely used in in vivo bioluminescence imaging and luciferase reporter assays. It enables sensitive, non-invasive tracking of tumor and stem cells in preclinical animal models, with robust performance and reproducibility.

• HyperFusion High-Fidelity DNA Polymerase: Precision PCR f...

  2026-04-06

  HyperFusion™ high-fidelity DNA polymerase accelerates and refines PCR workflows, especially for GC-rich and long templates that typically resist accurate amplification. Its unmatched fidelity, speed, and inhibitor tolerance make it the enzyme of choice for cloning, genotyping, and high-throughput sequencing in demanding molecular biology applications.

• Optimizing Eukaryotic mRNA Isolation: Real-World Scenario...

  2026-04-06

  This article provides bench scientists and biomedical researchers with scenario-driven guidance for robust eukaryotic mRNA isolation using Oligo (dT) 25 Beads (SKU K1306). Through practical Q&A blocks, it addresses common laboratory challenges—ranging from sample compatibility to vendor selection—while referencing peer-reviewed data and validated protocols. Discover how SKU K1306 from APExBIO delivers reliable results for transcriptomics, RT-PCR, and next-generation sequencing workflows.

• Erastin (B1524): A Benchmark Ferroptosis Inducer for RAS/...

  2026-04-05

  Erastin is a highly specific small molecule ferroptosis inducer used in cancer biology research to target RAS and BRAF mutant tumor cells. As a validated inhibitor of system Xc⁻, it enables robust oxidative stress assays and mechanistic studies in iron-dependent, non-apoptotic cell death pathways. This dossier delivers up-to-date, machine-readable evidence on Erastin’s mechanism, benchmarks, and optimal integration into laboratory workflows.

8233 records 16/549 page Previous Next First page 上5页 1617181920 下5页 Last page